Single-Use Bioprocessing Market: Current Analysis and Forecast (2021-2027)

Single-use systems are biopharmaceutical production (bioprocessing) products that are only used once and then discarded. Single-use systems are often made up of plastic components that have been disinfected and sealed using gamma irradiation. The prevalence of chronic diseases has been continuously increasing worldwide. They are the world's leading killers, accounting for more than 63% of all deaths. If nothing is done to reverse this trend, the number of people dying from chronic diseases will increase by 17% in the following ten years. This has led to expanding clinical research activities to decipher the potential of biotherapeutics against various disease areas is expected to have a positive influence on the market for single-use bioprocessing.
Single-use bioprocessing in biopharmaceutical firms is expected to see healthy expansion in the future because of its numerous advantages over traditional bioprocessing technologies. These technologies have several advantages, including lower initial investment and R&D costs, lower labor and material costs, and the ability to be readily disposed of. Furthermore, as compared to stainless steel reactors used in conventional bioprocessing, these single-use bioprocessing units have a 35% better CO2 balance, which is why they are widely used by the manufacturer. Merck KGaA announced an extra EUR 40 million investment in Asia in 2018 for two years to establish a solid manufacturing and distribution network.
Furthermore, the increasing approval of drugs and other biologics has increased the demand for single-use disposables such as media bags and containers. The Center for Drug Evaluation and Research (CDER) approved 53 new medications in 2020. (CDER). Each year, the number of new medicinal items approved by the FDA fluctuates greatly: in 2016, just over 20 new pharmaceuticals were approved, while in 2018, almost 60 new products were approved. In the year 2020, 53 new medicines were approved. In 2019, many new pharmaceuticals will be developed, notably in the pharmaceutical business in the United States. Under the United States alone, nearly 1,100 novel drugs were in development for cancer and cancer-related illnesses as of April 2019. Hundreds of innovative treatments for uncommon ailments, neurological disorders, and skin diseases were also in the works.
Thermo Fisher Scientific, Inc., Merck KGaA, Sartorius AG, Corning Incorporated, Pall Corporation, General Electric Company (GE Healthcare), Eppendorf AG, Rentschler Biopharma SE, Lonza, and Meissner Filtration Products, Inc are some of the prominent players operating in the global Single-Use Bioprocessing market. Several M&A’s along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst Product Type, Media Bags and Containers segment holds the major share”
Based on the product type, the market is fragmented into media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others. The media bags and containers segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the growing adoption of media bags and containers in transportation and storage.
Amongst Applications, Filtration segment holds the major share”
Based on the application, the market is fragmented into filtration storage, cell culture, mixing, and purification. The filtration segment dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period. Furthermore, the segment is also expected to grow at the highest CAGR during the period.
“Amongst End-User, biopharmaceutical manufacturers segment dominated the market”
Based on end-user, the market is fragmented into life science R&D and biopharmaceutical manufacturers. In 2020, biopharmaceutical manufacturers accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period.
“North America signifies one of the largest markets of Single-Use Bioprocessing Market”
For a better understanding of the market dynamics of the Single-Use Bioprocessing market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to the increased prevalence of chronic diseases and outbreak of COVID-19. The North American government has been investing heavily in the development of COVID-19 vaccines, treatments, and diagnostic tests, which is expected to increase demand for single-use bioreactors and, as a result, overall market growth.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
The Single-Use Bioprocessing Market can further be customized as per the requirement or any other market segment. Besides this, understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.